- Home
- YORW vs TYRA Comparison
YORW vs TYRA Comparison
Compare YORW & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- TYRA
- Stock Information
- Founded
- YORW 1816
- TYRA 2018
- Country
- YORW United States
- TYRA United States
- Employees
- YORW N/A
- TYRA N/A
- Industry
- YORW Water Supply
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- TYRA Health Care
- Exchange
- YORW Nasdaq
- TYRA Nasdaq
- Market Cap
- YORW 481.3M
- TYRA 576.6M
- IPO Year
- YORW N/A
- TYRA 2021
- Fundamental
- Price
- YORW $32.07
- TYRA $10.26
- Analyst Decision
- YORW
- TYRA Strong Buy
- Analyst Count
- YORW 0
- TYRA 7
- Target Price
- YORW N/A
- TYRA $30.86
- AVG Volume (30 Days)
- YORW 66.7K
- TYRA 310.4K
- Earning Date
- YORW 08-01-2025
- TYRA 05-08-2025
- Dividend Yield
- YORW 2.73%
- TYRA N/A
- EPS Growth
- YORW N/A
- TYRA N/A
- EPS
- YORW 1.37
- TYRA N/A
- Revenue
- YORW $75,787,000.00
- TYRA N/A
- Revenue This Year
- YORW $7.50
- TYRA N/A
- Revenue Next Year
- YORW $6.33
- TYRA N/A
- P/E Ratio
- YORW $23.46
- TYRA N/A
- Revenue Growth
- YORW 3.45
- TYRA N/A
- 52 Week Low
- YORW $29.86
- TYRA $6.42
- 52 Week High
- YORW $41.96
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- YORW 39.62
- TYRA 57.68
- Support Level
- YORW $31.98
- TYRA $8.88
- Resistance Level
- YORW $33.06
- TYRA $9.68
- Average True Range (ATR)
- YORW 0.64
- TYRA 0.65
- MACD
- YORW -0.01
- TYRA 0.03
- Stochastic Oscillator
- YORW 13.31
- TYRA 79.89
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.